Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 066536/0717 | |
| Pages: | 6 |
| | Recorded: | 02/22/2024 | | |
| Attorney Dkt #: | 329744/123 |
| Conveyance: | RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
9
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/24/2018
|
Application #:
|
15340428
|
Filing Dt:
|
11/01/2016
|
|
Publication #:
|
|
Pub Dt:
|
05/04/2017
| | | | |
|
Title:
|
INHIBITORS OF RET
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/10/2020
|
Application #:
|
16041719
|
Filing Dt:
|
07/20/2018
|
|
Publication #:
|
|
Pub Dt:
|
06/20/2019
| | | | |
|
Title:
|
INHIBITORS OF RET
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/22/2022
|
Application #:
|
16775646
|
Filing Dt:
|
01/29/2020
|
|
Publication #:
|
|
Pub Dt:
|
12/31/2020
| | | | |
|
Title:
|
INHIBITORS OF RET
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/23/2024
|
Application #:
|
17061743
|
Filing Dt:
|
10/02/2020
|
|
Publication #:
|
|
Pub Dt:
|
03/25/2021
| | | | |
|
Title:
|
RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/15/2022
|
Application #:
|
17127041
|
Filing Dt:
|
12/18/2020
|
|
Publication #:
|
|
Pub Dt:
|
04/08/2021
| | | | |
|
Title:
|
RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17267149
|
Filing Dt:
|
02/09/2021
|
|
Publication #:
|
|
Pub Dt:
|
10/07/2021
| | | | |
|
Title:
|
TREATMENT OF EGFR-MUTANT CANCER
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/16/2024
|
Application #:
|
17377885
|
Filing Dt:
|
07/16/2021
|
|
Publication #:
|
|
Pub Dt:
|
06/09/2022
| | | | |
|
Title:
|
RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17669785
|
Filing Dt:
|
02/11/2022
|
|
Publication #:
|
|
Pub Dt:
|
10/06/2022
| | | | |
|
Title:
|
INHIBITORS OF RET
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18000166
|
Filing Dt:
|
11/29/2022
|
|
Publication #:
|
|
Pub Dt:
|
06/29/2023
| | | | |
|
Title:
|
PRALSETINIB PHARMACEUTICAL COMPOSITIONS
|
|
|
Assignee
|
|
|
|
|
| 45 SIDNEY STREET |
| CAMBRIDGE, MASSACHUSETTS 02139 |
|
|
Correspondence name and address
|
| |
JENNIFER FITZPATRICK
|
| |
C/O COOLEY LLP
|
| |
1299 PENNSYLVANIA AVENUE, NW, STE 700
|
| |
WASHINGTON, DC 20004
|
Search Results as of:
05/22/2024 11:01 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
